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Abstract We examined the effects of erythroid differentiation 
factor (EDF)lactivin A on the expression of c-kit mRNA and 
protein in murine erythroleukemia (MEL) cells. EDFlactivin A 
induced MEL cells to benzidine positive cells. Northern blot anal- 
ysis showed that the c-kit mRNA expression was reduced syn- 
chronously with increase of i~-globin and uroporphyrinogen de- 
carboxylase gene expression during EDFlactivin A induced 
erythroid differentiation. Scatchard analysis indicated that the 
cell surface receptor number was reduced without change of affin- 
ity during differentiation. Our results suggest hat EDF/activin 
A may act as a natural regulator of erythropoiesis with modula- 
tion of c-kit gene expression. 
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1. Introduction 
All blood cells are derived from a few common pluripotent 
stem cells. Several cytokines regulate the proliferation and dif- 
ferentiation of hematopoietic stem cells, Erythroid differentia- 
tion factor (EDF), which was isolated from conditioned media 
of phorbol ester-treated THP-1 cells, has a potent differentia- 
tion-inducing activity for murine erythroleukemia (MEL) cells 
[1]. A subsequent study showed that EDF was identical to 
activin A that was first purified from ovarian fluid as a factor 
to stimulate the secretion of pituitary follicular-stimulating 
hormone [2]. Several reports have shown that activin A can 
modulate the colony formation of erythroid burst-forming 
units and erythroid colony-forming units [3-5]. In addition, 
Yamashita et al. have reported that bone marrow stromal cells 
produce EDF/activin A [6]. These results suggest hat EDF/ 
activin A possibly acts as a natural regulator of erythropoiesis 
in the bone marrow. However, the mechanism of the action of 
EDF/activin A on the process of erythropoiesis remains largely 
unclear. 
The proto-oncogene c-kit [7,8], which is a receptor for stem 
cell factor (SCF) [9-14], plays a critical role in early hematopoi- 
esis. Mutations at the murine dominant-white spotting locus 
that maps to c-kit cause severe anemia [15]. In addition, c-kit 
antisense oligonucleotides inhibit the colony-forming ability of 
CD34 positive cells cultured in the presence of interleukin-3 
(IL-3) [16]. These results suggest hat the regulators of c-kit 
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expression can have profound effects on hematopoiesis. In this 
report, we demonstrated modulation of c-kit expression during 
EDF/activin A induced erythroid ifferentiation of MEL cells. 
2. Materials and methods 
2.1. Growth factors and probes 
Recombinant EDF/activin A was kindly provided by Ajinomoto Co. 
Inc. Recombinant murine SCF was kindly provided by Kirin-Amgen 
Inc. SCF was iodinated by the ehloramine-T method with a minor 
modification as described elsewhere [17]. Briefly, SCF (5 pg), 0.5 mCi 
of Na~25I, and chloramine-T (3.75 pg/ml) in 30 ,ul of 0.3 M sodium 
phosphate (pH 7.4) were placed in a 1.5-ml polypropylene tube. The 
iodination reaction was continued for 10 min at 22°C and stopped by 
addition of 5 pl of sodium metabisulfite (60 pg/ml). Labeled SCF was 
separated from free t25I by column chromatography using a Sephadex 
G-25 (Pharmacia Fine Chemicals, Uppsala, Sweden). Murine c-kit 
eDNA was derived from mRNA of F5-5 murine rythroleukemia cells 
by reverse transcriptase polymerase chain reaction (RT-PCR) tech- 
nique [18] with sense primer (5'-AGACGCTGACTATCAGCTC-Y) 
and antisense primer (5'-TGGCATCAGAGTTGGACA-3') according 
to the previously published cDNA sequence [8]. Amplified 381 bp 
fragment was cloned into TA cloning vector (Invitrogen Co., San 
Diego, CA) and identified by DNA sequencing. Murine c-kit, fl-globin 
[19], fl-actin [20], uroporphyrinogen decarboxylase (UPD) [21] cDNA 
fragments were electrophoretically purified from agarose gels and la- 
beled by using hexadeoxynncleotide random primers (Amersham Inter- 
national, Buckinghamsire, UK) with [~-32P]dCTP (specific activity 111 
TBq/mmol; NEN Research Products, Boston, MA). 
2.2. Culture and differentiation i duction of MEL cells by 
EDF/activin A 
A MEL cell line F5 5 [22] was maintained in Ham's F-12 medium 
containing 10% fetal calf serum (GIBCO, Grand Island, NY), penicillin 
(100 units/ml), and streptomycin (100 pg/ml) at 37°C in a humidified 
atmosphere containing 95% air, 5% CO,,. EDF/activin A (100 ng/ml) 
was added to the cell suspension (1 x 103/ml) at day 0 for differentiation 
induction [23]. On day 5, the cells were harvested for [1251]SCF binding. 
The degree of differentiation was measured by scoring the ratio of 
benzidine staining positive cells. 
2.3. Assay Jor binding of [I:~I]SCF 
F5 5 cells were incubated with [~25I]SCF in s-medium containing 
0.1% bovine serum albumin, 20 mM HEPES, and 0.02% sodium azide 
(pH 7.4) at 15°C for 60 min. The cells were separated from unbound 
[~25I]SCF by centrifugation  a cushion of di-n-butyl phthalate. The 
radioactivity associated with the pellets was counted in an automatic 
gamma counter. Specific binding was determined by subtracting the 
non-specific binding measured in the presence of 100-fold excess unla- 
beled murine SCF from total binding. 
2.4. Northern blot analysis 
Total cellular RNA was prepared from F5-5 cells by the acid gua- 
nidium-thiocyanate ph nol-chloroform method [24] and electrophore- 
sed in 1% agarose gel containing formaldehyde. RNA was transferred 
to a nylon filter and hybridized with 32p-labeled murine c-kit, UPD, 
fl-globin, and fl-actin cDNA as probes in 50% formamide, 3 × SSC 
(1 x SSC is 0.15 M NaCI and 0.015 M sodium citrate, pH 7.4), 50 mM 
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Tris-HC1 (pH 7.5), 0.1% SDS, 20/zg/ml tRNA, 20 pg/ml boiled salmon 
sperm DNA, 1 mM EDTA, 0.02% bovine serum albumin, 0.2% polyvi- 
nylpyrolidone, and 0.02% Ficoll for 40 h at 37°C. The nylon mem- 
branes were washed with 2 × SSC, 1% SDS, and 1 × Denhardt at 37°C 
for 1 h, followed by 0.1 x SSC and 1% SDS at 50°C for 1 h and then 
underwent autoradiography using intensifying screens at -80°C. 
3. Resu l ts  
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Fig. 1 shows the change in the binding of [~25I]SCF to F5-5 
cells and ratio of benzidine positive cells during the erythroid 
differentiation i duced by EDF/activin A. After treatment with 
100 ng/ml of EDF/activin A, specific binding of SCF to F5-5 
cells gradually decreased up to day 5. In contrast, differentiated 
erythroid cells producing hemoglobin appeared after day 2 and 
progressively increased in ratio. To clarify the observation ob- 
tained above, we tried saturation analysis of [~25I]SCF binding 
to both untreated and EDF/activin A-treated F5-5 cells. 
Scatchard analysis [25] of the binding data indicated a single 
class of binding sites with a dissociation constant (Kd) of 
3.8 × 10 -j° M and 2.8 x 10 -j° M, respectively. The total number 
of binding sites were estimated at 2442/cell and 265/ce11, respec- 
tively (Fig. 2). These results suggested that the apparent de- 
crease in specific [J25I]SCF binding by EDF/activin A treatment 
was caused for a major part by a change in the binding sites 
in F5-5 cells. 
Total RNA prepared from F5-5 cells after incubation with 
100 ng/ml of EDF/activin A for up to 120 h, was hybridized 
with the murine c-kit, UPD, fl-globin, and fl-actin cDNA as 
probes (Fig. 3). Expression offl-globin and UPD mRNA signif- 
icantly increased uring erythroid ifferentiation. In contrast, 
expression of c-kit mRNA rapidly decreased uring erythroid 
differentiation. 
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Fig. 1. Change in specific [~25I]SCF binding to F5 5 cells and ratio of 
benzidine-positive cells during EDF/activin A-induced erythroid iffer- 
entiation. F5-5 cells were incubated with 100 ng/ml EDF/activin A and 
harvested after the indicated period. A portion of the cells was stained 
with benzidine dye, and the ratio of positive cells (•) was scored as the 
percentage of the total. Specific [J2sI]SCF binding (<3) was determined 
as described in section 2. 
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Fig. 2. Scatchard analysis of [~25I]SCF binding to F5-5 cells. The undif- 
ferentiated (•) and differentiated (©) cells (1 × 106) were incubated with 
increased concentrations of [~2sI]SCF in the presence or absence of 
excess unlabeled SCF at I5°C for 60 min. Specific binding was deter- 
mined as described insection 2. Each data point is the mean of duplicate 
determinations. 
4. D iscuss ion  
In this report, we demonstrated that a potent erythroid if- 
ferentiation inducer EDF/activin A down-regulated c-kit ex- 
pression both at mRNA and protein levels synchronously with 
increase offl-globin and UPD during erythroid ifferentiation. 
SCF, the ligand for c-kit, enhances the growth of primitive 
hematopoietic progenitor cells synergistically with hematopoi- 
etic growth factors such as IL-3, granulocyte-macrophage col- 
ony-stimulating factor (GM-CSF), and granulocyte colony- 
stimulating factor in vitro [9-11]. These results suggest hat 
SCF and c-kit system play an important role in early hemato- 
poiesis. Anderson et al. have shown two forms of SCF that arise 
through differential RNA processing: a membrane-bound form 
and a soluble secreted form [11]. The transfected COS cells 
expressing murine surface SCF adhered with murine mast cells, 
suggesting that the membrane-bound molecule may act as an 
adhesion molecule [26]. Avraham et al. have reported that ad- 
hesion of human megakaryocytes could be mediated in part via 
their c-kit receptor binding to membrane-associated SCF ex- 
pressed by bone marrow fibroblasts [27]. They have also re- 
ported that this interaction results in bone marrow fibroblast- 
stimulated megakaryocytic cell proliferation [27]. These reports 
suggest hat early hematopoietic progenitor cells may be an- 
chored to stromal elements within the bone marrow microenvi- 
ronment suitable for the expansion by direct interaction of SCF 
to c-kit. Ogawa et al. have shown that the intensity of c-kit 
expression on bone marrow progenitor cells decrease with mat- 
uration [28]. Welham et al. have reported that IL-3, GM-CSF, 
and erythropoietin (EPO) down-regulate l vels of c-kit mRNA 
[29]. Down-regulation of c-kit expression could be one of the 
molecular mechanisms mediated by cytokines, which causes the 
release of stem cells from the bone marrow into circulation 
when required, such as in hemorrhage or infection. Our find- 
ings, down-regulation of c-kit expression by EDF/activin A, 
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Fig. 3. Relative levels of c-kit mRNA in F5-5 cells during EDF/activin 
A-induced erythroid ifferentiation. F5-5 cells were incubated with 100 
ng/ml EDF and harvested after the indicated period. Total RNA (20 
/.tg) prepared from these cells were electrophoresed, transferred, and 
hybridized with murine c-kit, UPD, ]~-globin, and,8-actin cDNA as the 
probes. 
suggest hat EDF/activin A may also play an important role in 
release of erythroid progenitor cells from bone marrow into 
circulation like EPO, when required. These possibilities hould 
be addressed with further investigations. 
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